
    
      Phase 3 clinical trial is designed to examine the efficacy and safety of inhaled prandial TI
      Inhalation Powder in combination with basal insulin verses insulin aspart in combination with
      basal insulin in subjects with type 2 diabetes who are suboptimally controlled with their
      current insulin regimens.This trial will employ a variety of methods to intensively manage
      these subjects.
    
  